Suppressive effects of gemcitabine plus cisplatin chemotherapy on regulatory T cells in nonsmall-cell lung cancer

Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy

(2013) Guohong Song et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cyclophosphamide inhibits the generation and function of CD8+ regulatory T cells

(2012) Ilaria Traverso et al.   HUMAN IMMUNOLOGY

Influence of anticancer agents on cell survival, proliferation, and CD4+CD25+Foxp3+ regulatory T cell-frequency in human peripheral-blood mononuclear cells activated by T cell-mitogen

(2012) Naoya Tohyama et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses

(2011) Sofia R. Gameiro et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer

(2011) Suliman Y. Al Omar et al.   IMMUNOLOGY

The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy

(2011) Elizabeth A. Vasievich et al.   MOLECULAR PHARMACEUTICS

Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy

(2008) Lei Zhang et al.   CLINICAL IMMUNOLOGY